Literature DB >> 21722608

Hemolytic uremic syndrome and rhabdomyolysis in a patient with succinate coenzyme Q reductase (complex II) deficiency.

M V Micheletti1, G Lavoratti, S Gasperini, M A Donati, I Pela.   

Abstract

Hemolytic uremic syndrome (HUS) is characterized by microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure. Besides diarrhea-associated HUS, due to verotoxin-producing Escherichia coli, in children HUS without prodromal diarrhea may be associated with other infectious and autoimmune diseases, genetic defects of the complement-regulator alternative-pathway, and inborn errors of vitamin B12 metabolism. Rhabdomyolysis is the dissolution of skeletal muscle due to various causes, including inborn errors of metabolism. Recurrent rhabdomyolysis and HUS have been previously described in one patient with a genetic defect of oxidative phosphorylation. We report the case of a 2-year-old boy with recurrent HUS and rhabdomyolysis in whom a succinate coenzyme Q reductase (complex II) deficiency was diagnosed. We hypothesize that defects of oxidative phosphorylation could be another etiological factor in atypical HUS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21722608     DOI: 10.5414/cn106681

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

Review 1.  Current treatment of atypical hemolytic uremic syndrome.

Authors:  Bernard S Kaplan; Rebecca L Ruebner; Joann M Spinale; Lawrence Copelovitch
Journal:  Intractable Rare Dis Res       Date:  2014-05

2.  Increased frequency of rhabdomyolysis in familial dysautonomia.

Authors:  Jose-Alberto Palma; Ricardo Roda; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Muscle Nerve       Date:  2015-08-13       Impact factor: 3.217

3.  Haematological abnormalities in mitochondrial disorders.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Singapore Med J       Date:  2015-07       Impact factor: 1.858

Review 4.  Extra-renal manifestations of complement-mediated thrombotic microangiopathies.

Authors:  Johannes Hofer; Alejandra Rosales; Caroline Fischer; Thomas Giner
Journal:  Front Pediatr       Date:  2014-09-08       Impact factor: 3.418

5.  Evolutionarily conserved susceptibility of the mitochondrial respiratory chain to SDHI pesticides and its consequence on the impact of SDHIs on human cultured cells.

Authors:  Paule Bénit; Agathe Kahn; Dominique Chretien; Sylvie Bortoli; Laurence Huc; Manuel Schiff; Anne-Paule Gimenez-Roqueplo; Judith Favier; Pierre Gressens; Malgorzata Rak; Pierre Rustin
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

Review 6.  Drug induced rhabdomyolysis.

Authors:  Martin Hohenegger
Journal:  Curr Opin Pharmacol       Date:  2012-05-05       Impact factor: 5.547

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.